Trends in the use of short‐course radiation therapy for rectal cancer in New South Wales, Australia
暂无分享,去创建一个
S. Vinod | J. Descallar | G. Delaney | V. Batumalai | J. Shafiq | Karen Wong | G. Gabriel | Michael B Barton
[1] T. Conroy,et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.
[2] Charles R. Thomas,et al. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. , 2020, Practical radiation oncology.
[3] W. Bemelman,et al. Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] M. Barton,et al. Estimating the cost of radiotherapy for 5-year local control and overall survival benefit. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] D. Trifiletti,et al. Short‐course Versus Long‐course Neoadjuvant Therapy for Non‐metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database , 2018, Clinical colorectal cancer.
[6] E. B. Butler,et al. Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States. , 2018, Journal of gastrointestinal oncology.
[7] L. Wyrwicz,et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] D. Joseph,et al. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04) , 2017, Annals of surgery.
[9] P. Quirke,et al. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).
[10] D. Aust,et al. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. , 2016, European journal of cancer.
[11] D. Goldstein,et al. The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04). , 2016, European journal of cancer.
[12] D. Goldstein,et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Mariusz Pawlak,et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] K. Bujko,et al. Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer , 2006, The British journal of surgery.
[15] K. Bujko,et al. Postoperative complications in patients irradiated pre‐operatively for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs chemoradiation , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[16] H. Quan,et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.